Skip to main content
Mega Genomics Limited logo

Mega Genomics Limited — Investor Relations & Filings

Ticker · 6667 ISIN · KYG5960G1047 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 319 across all filing types
Latest filing 2026-05-21 Notice of Dividend Amou…
Country HK Hong Kong
Listing HKEX 6667

About Mega Genomics Limited

https://www.megagenomics.cn

Mega Genomics Limited operates as a genetic testing platform company focused on providing consumer genetic testing and cancer screening services. The core business involves delivering comprehensive genetic analysis solutions to the consumer market. Key product offerings include advanced sequencing packages such as Personal Whole Genome Sequencing, which analyzes over 700,000 genetic loci to assess disease risk and provide pharmacogenomic recommendations. Additionally, the company offers Adult and Children's Whole Exome Sequencing packages, which analyze over 180,000 key exome regions to evaluate risks for high-risk diseases, hereditary cancers, and complex genetic disorders, alongside personalized guidance on drug efficacy, nutrition, and fitness.

Recent filings

Filing Released Lang Actions
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025
Notice of Dividend Amount Classification · 90% confidence The document is an EF001 ‘‘Cash Dividend Announcement for Equity Issuer’’ on the Hong Kong Exchange, detailing the final dividend amount, currency conversion, ex-dividend date, record date, payment date, and related share registrar information. This matches the definition for a Notice of Dividend Amount (DIV).
2026-05-21 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON THURSDAY, 21 MAY 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an exchange announcement reporting the poll results of resolutions at the Annual General Meeting, including votes for and against on each resolution and dividend approval details. It does not contain full financial statements or call transcripts, but is a formal declaration of shareholder voting outcomes. This matches the "Declaration of Voting Results & Voting Rights Announcements" category.
2026-05-21 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2026
Regulatory Filings Classification · 95% confidence The document is a monthly return filing (Form FF301) submitted to the Hong Kong Exchanges and Clearing Limited (HKEX) regarding movements in securities for the month ended 30 April 2026. It details movements in authorized share capital, issued shares, public float sufficiency confirmation, and confirmations related to compliance with listing rules. It is a regulatory compliance report about share capital and share movements, not a financial report, earnings release, or management discussion. It does not contain financial statements or earnings data, nor is it an announcement of voting results or management changes. The document is a regulatory filing required by the exchange to report share capital movements and confirmations. Therefore, it fits best under Regulatory Filings (RNS). The document length (7760 characters) and content confirm it is a substantive regulatory filing, not a brief announcement or certification only.
2026-05-05 English
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025
Notice of Dividend Amount Classification · 92% confidence The document is a formal announcement by Mega Genomics Limited under Hong Kong Exchange format, detailing the final dividend for the year ended 31 December 2025. It provides the dividend type, amount per share, important dates (ex-dividend date, record date, payment date), withholding tax, and related shareholder registration information. This matches the definition of a Notice of Dividend Amount (Code: DIV).
2026-04-28 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 21 MAY 2026
Proxy Solicitation & Information Statement Classification · 94% confidence The document is a Form of Proxy for the Annual General Meeting, which is used to solicit votes and appoint proxies for shareholder meetings. This falls under “Proxy Solicitation & Information Statement” rather than an actual report or results announcement.
2026-04-28 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 93% confidence The document is a formal “Notice of Annual General Meeting” describing the date, agenda items (financial statements, director elections, dividends, share repurchase and issue mandates), proxy instructions and meeting procedures. It is clearly materials sent to shareholders to provide information ahead of voting at the AGM, matching the “Proxy Solicitation & Information Statement” category. It is not the AGM presentation itself (AGM-R), not the full annual report (10-K), and not a post-meeting voting result (DVA).
2026-04-28 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.